Onyx Pharma Rises Despite Deutsche Downgrade
July 22, 2013 at 12:55 PM EDT
Takeout speculation surrounding cancer drug maker Onyx Pharmaceuticals (ONXX) continued today, sending the stock rising 3% to $130.20 early Monday afternoon. Yet some analysts have cooled on the stock. Earlier today, Deutsche Bank downgraded Onyx to from a Buy to a Hold arguing that a potential deal is already baked into the stock price, leaving [...]
